UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Learn about various ways to earn money quickly that can fit into your busy schedule. Start increasing your cash flow today!
18,991 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
SK Hynix shares rebound 8% amid bargain-hunting after HSBC reaffirmed SKHY as a top chip pick. The move comes as inve...
March could reveal a powerful momentum move for a marquee AI stock. Learn why this genius stock that could surge on A...
A new covered-call ETF chasing a fat income stream uses the Russell 2000 as its base. This piece explains the mechani...
Oil prices retreat eased inflation fears, lifting bond prices worldwide. European bonds join treasury momentum as yie...
Bitcoin spot ETFs posted a green week after weeks of outflows, while Ethereum ETFs drew stronger inflows, underscorin...
A trio of analyst moves targets Accenture, Thomson Reuters and TELUS, reflecting divergent bets on AI demand, margins...
As mortgage costs ease slightly and new listings rise, starter home affordability crawling back is taking hold in sev...
Aave CEO Stani Kulechov unveiled a framework to speed up DAO decisions, following a governance dispute that saw BGD L...
A respected investment firm hints that the crypto market might be near a bottom. Here’s what that could mean for Coin...
Kohl's stock moved in dramatic strides after its latest earnings report, tumbling early before a sharp rally. This ar...
As Citi gears up for its 2026 earnings call, investors need a clear view of the revenue mix, credit quality, and capi...